Search Within

MSK Grad Students

  1. "Gottfried Von Keudell"
Formats
  1. Meeting Abstract (30)
  2. Journal Article (14)
  3. Review (6)
  4. Correspondence (3)
  5. Editorial (1)
Groups
  1. CTCR Scholars (54)
  2. Department of Medicine (54)
  3. Hematologic Malignancies, Division of (54)
  4. Master of Science in Clinical and Translational Cancer Research (54)
  5. Center for Hematologic Malignancies (44)
  6. Lymphoma (38)

More Groups

People
  1. Gottfried Von Keudell (54)
  2. Andrew Zelenetz (31)
  3. Matthew Matasar (30)
  4. Alison Moskowitz (29)
  5. Ariela Noy (29)
  6. Erel Joffe (29)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (8)
  4. 2021 (17)
  5. 2020 (12)
  6. 2019 (14)
Publications
  1. Blood (21)
  2. Journal of Clinical Oncology (6)
  3. Hematological Oncology (4)
  4. Leukemia and Lymphoma (4)
  5. Blood Advances (3)
  6. Blood Cancer Journal (3)

More Publications

Publishers
  1. American Society of Hematology (24)
  2. American Society of Clinical Oncology (6)
  3. Nature Publishing Group (4)
  4. Taylor & Francis Group (4)
  5. Wiley Blackwell (4)
  6. Elsevier Inc. (2)

More Publishers

Results (54)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 trial of abexinostat with ibrutinib in relapsed/refractory mantle cell lymphoma and non-germinal center diffuse large B cell lymphoma
    Correspondence

    Gurumurthi, A.; Bantilan, K. S.; Hamlin, P. A.; Kumar, A.; Matasar, M.; Zhu, M.; Joseph, A.; Castro, A.; Biggar, E.; Salles, G.; more...
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study
    Journal Article

    Ansell, S. M.; Bröckelmann, P. J.; von Keudell, G.; Lee, H. J.; Santoro, A.; Zinzani, P. L.; Collins, G. P.; Cohen, J. B.; de Boer, J. P.; Kuruvilla, J.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with positive interim positron emission tomography (PET) continuing ABVD in the clinical setting
    Journal Article

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S.; Kumar, A.; Matasar, M. J.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • MSK-ACCESS Heme: A cell-free DNA next-generation sequencing assay to identify somatic alterations in patients with lymphoma
    Meeting Abstract

    DiNapoli, S. E.; Spence, C.; Gedvilaite, E.; Bowman, A.; Diosdado, M.; Razumova, A.; Tsui, D.; Salles, G. A.; Batlevi, C.; von Keudell, G.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Validation of a cell-free DNA NGS assay for hematological malignancies
    Meeting Abstract

    Gedvilaite, E.; DiNapoli, S.; Spence, C.; Diosdado, M. S.; Razumova, A.; Bowman, A. S.; Tsui, D. W. Y.; Salles, G.; Batlevi, C. L.; von Keudell, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • TTI-622-01: A phase 1a/1b dose-escalation and expansion trial of TTI-622 in patients with advanced hematologic malignancies, including diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Patel, K.; Sano, D.; Maris, M.; Lesokhin, A. M.; Von Keudell, G.; Doucette, K.; Ramchandren, R.; Pavlov, D.; Uger, R. A.; Molloy, N.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • CD19 epitope masking by tafasitamab leads to delays in subsequent use of CD19 CAR T-cell therapy in two patients with aggressive mature B-cell lymphomas
    Correspondence

    Fitzgerald, K. N.; Quesada, A. E.; von Keudell, G.; Raj, S.; Lewis, N. E.; Dogan, A.; Salles, G.; Palomba, M. L.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: A single-center experience
    Journal Article

    Pak, T. K.; Dixon, B. N.; Buege, M. J.; Dao, P. H.; Leary, M. H.; Jarrett, J. C.; Duggan, T. A.; Caron, P.; Falchi, L.; Hamlin, P.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma
    Journal Article

    Halwani, A. S.; Panizo, C.; Isufi, I.; Herrera, A. F.; Okada, C. Y.; Cull, E. H.; Kis, B.; Chaves, J. M.; Bartlett, N. L.; Ai, W.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma
    Journal Article

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save